K132281

Substantially Equivalent

ReVive PV (Peripheral Vasculature) Thrombectomy Device

Applicant: Codman & Shurtleff, Inc.
Product code: QEW
Advisory panel: Cardiovascular
Date received: 2013-07-23
Decision date: 2013-08-30
Decision: Substantially Equivalent
Clearance type: Special
Location: Raynham, MA, US

Adverse events under product code QEW

product code QEW

Death: 126
Injury: 282
Malfunction: 820
Total: 1,228

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.